Mayo Clinic: Liver Diseases trials
The registry lists 17 Liver Diseases studies with Mayo Clinic as lead sponsor. 1 are open to participants now and 8 have results posted.
Phase 1 1Phase 2 4Phase 3 2No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary ComplicationsNot yet recruitingNCT06649864Phase 1
- A Study to Evaluate Liver Stiffness With Shear Wave ElastographyCompletedNCT05097963Not applicableResults posted
- Breath Analysis Based Disease BiomarkersCompletedNCT04341012Results posted
- Acamprosate Safe to Use in Individuals With Liver Disease.CompletedNCT04287920Phase 2Results posted
- Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) StudyCompletedNCT03154476Phase 3Results posted
- Pasireotide LAR in Severe Polycystic Liver DiseaseCompletedNCT01670110Phase 2Results posted
- Polycystic Liver Disease in Kidney TransplantTerminatedNCT00934791Not applicableResults posted
- Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic TelangiectasiaTerminatedNCT00588146Phase 2Results posted
- Octreotide in Severe Polycystic Liver DiseaseCompletedNCT00426153Phase 2/3Results posted
- Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC)CompletedNCT06319222Not applicable
- Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2CompletedNCT05081427
- Pulmonary Rehabilitation in End-Stage Liver DiseaseTerminatedNCT03266575Not applicable
- Extracellular RNA Markers of Liver Disease and CancerTerminatedNCT02908048
- Transforming Non-Invasive Liver Disease Detection by MRE: The HepatogramCompletedNCT02565446Not applicable
- Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).CompletedNCT02173080
- Cardiopulmonary Exercise Testing in Cirrhotic Patients: a Pilot StudyCompletedNCT01658982
- Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic SteatohepatitisCompletedNCT01324414